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Abstract
Background: Previous studies have shown decreases in cardiovascular mortality following the implementation of
comprehensive smoking bans. It is not known whether cerebrovascular or respiratory mortality decreases post-ban. On
March 29, 2004, the Republic of Ireland became the first country in the world to implement a national workplace smoking
ban. The aim of this study was to assess the effect of this policy on all-cause and cause-specific, non-trauma mortality.
Methods: A time-series epidemiologic assessment was conducted, utilizing Poisson regression to examine weekly age and
gender-standardized rates for 215,878 non-trauma deaths in the Irish population, ages $35 years. The study period was
from January 1, 2000, to December 31, 2007, with a post-ban follow-up of 3.75 years. All models were adjusted for time
trend, season, influenza, and smoking prevalence.
Results: Following ban implementation, an immediate 13% decrease in all-cause mortality (RR: 0.87; 95% CI: 0.76–0.99), a
26% reduction in ischemic heart disease (IHD) (RR: 0.74; 95% CI: 0.63–0.88), a 32% reduction in stroke (RR: 0.68; 95% CI: 0.54–
0.85), and a 38% reduction in chronic obstructive pulmonary disease (COPD) (RR: 0.62; 95% CI: 0.46–0.83) mortality was
observed. Post-ban reductions in IHD, stroke, and COPD mortalities were seen in ages $65 years, but not in ages 35–64
years. COPD mortality reductions were found only in females (RR: 0.47; 95% CI: 0.32–0.70). Post-ban annual trend reductions
were not detected for any smoking-related causes of death. Unadjusted estimates indicate that 3,726 (95% CI: 2,305–4,629)
smoking-related deaths were likely prevented post-ban. Mortality decreases were primarily due to reductions in passive
smoking.
Conclusions: The national Irish smoking ban was associated with immediate reductions in early mortality. Importantly, post-
ban risk differences did not change with a longer follow-up period. This study corroborates previous evidence for
cardiovascular causes, and is the first to demonstrate reductions in cerebrovascular and respiratory causes.
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Introduction
Exposure to secondhand smoke increases the risk of morbidity
and premature mortality due to cardiovascular [1], cerebrovascu-
lar [2], and respiratory [1] causes. On March 29, 2004, the
Republic of Ireland became the first country in the world to
implement a national workplace smoking ban. The legislation was
comprehensive, banning smoking in workplaces including restau-
rants, bars, and pubs.
Following the implementation of the Irish national smoking
ban, studies conducted in pubs and bars demonstrated reductions
in particulate concentrations [3], reductions in worker-reported
exposure to secondhand smoke [4,5], and related improvements in
worker pulmonary function [3] and self-reported respiratory
symptoms [5]. More recent Irish studies have shown post-ban
reductions in hospital admissions due to acute coronary syndromes
[6,7] and acute pulmonary disease [7]. Epidemiological studies of
the effects of comprehensive smoking bans in other countries have
demonstrated reductions in mortality due to cardiovascular causes
[8–11] and hospital admissions due to cardiovascular [11–20],
cerebrovascular [12,20], and respiratory causes [12,20,21]. Most
of the studies analyzed a post-ban follow-up period of 2.5 years or
less [8–20], with only one study analyzing a post-ban time period
of 3.5 years [21]. None of the studies analyzed post-ban mortality
effects in cerebrovascular or respiratory causes. The aim of this
study was to assess the effect of the national smoking ban on all-
cause and cause-specific, non-trauma mortality in the Republic of
Ireland for the years 2000–2007.
Methods
Data for the Republic of Ireland
National mortality data from January 1, 2000, to December 31,
2007, were obtained from the Central Statistics Office (CSO)
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Ireland. From 2000–2006, mortality data were coded according to
the International Classification of Diseases, 9th Revision (ICD-9); ICD-10
codes were implemented in 2007. Primary causes of death selected
for analyses included all-cause, non-trauma mortality (ICD-9
codes 001-799/ICD-10 codes A00-R99), smoking-related mortal-
ity including all cardiovascular diseases (390-429/I01-I52), ische-
mic heart disease (IHD) (410-414, 429.2/I20-I25), acute myocar-
dial infarction (AMI) (410/I21), stroke (430-438/I60-I69), all
respiratory diseases (460-519/J0-J99), and chronic obstructive
pulmonary disease (COPD) (490–492, 494–496/J40–J44, J47).
Non-smoking related mortality (001–389, 440–459, 520–799/
A00–H95, I26–I52, K00–R99) was included as a control.
Age and gender-specific population estimates for the census
years 2002 and 2006 were obtained from the CSO Ireland [22].
Statistical Analyses
Poisson regression with interrupted time-series analysis was used
to calculate weekly mortality rates. The average of age and
gender-specific population figures for census years 2002 and 2006
was included as an offset in the models. Time was defined as a
continuous variable from week 1 of 2000 to week 51 of 2007 and
was included in the model to capture long-term trends in mortality
rates over time. Week 0 of 2000 and week 52 of 2007 were
excluded from analyses as some days fell in other calendar years.
An indicator variable was used to define the smoking ban, with
a value of zero given to the weeks before ban implementation and
a value of one given to the week of ban implementation (beginning
March 28, 2004) and all following weeks. An interaction term
between the smoking ban and time was defined to estimate the
monotonic change in the post-ban period. The analysis was
restricted to mortality events in age groups$35 years to reflect the
population at risk for smoking-related mortality.
Significant Durbin-Watson statistics indicated negative first-
order autocorrelation for the mortality data. To account for this,
terms specifying a first-order autoregressive structure were applied
to all models.
In 2007, the change in coding scheme from ICD-9 to ICD-10
resulted in a 43% decrease in pneumonia/influenza mortality
compared to 2006. Since roughly 49% of all respiratory mortality
was comprised of pneumonia/influenza over the 2000-2006 study
period, the large decrease in 2007 affected data reliability for this
category. Therefore, 2007 data were excluded from analyses of all
respiratory mortality. No other causes of death were affected by
the coding change.
To detect any differences between short-term and long-term
post-ban mortality effects, an additional indicator variable was
included in final models. Values of one were given for the week of
ban implementation and the subsequent weeks up to one, three,
six, or twelve months post-ban, with all other weeks denoted by a
value of zero.
For further validation that the final models were detecting true
ban effects, three additional models were refitted with false
smoking ban implementation dates set at six months, one year,
and two years pre-ban.
A peak in observed mortality was detected during the winter of
1999–2000; therefore, two additional models were tested to
determine whether the full inclusion (beginning December 1999)
or full exclusion (beginning April 2000) of the winter season
influenced model results.
To determine the modifying effects of age and gender on the
smoking ban-mortality association, analyses were stratified for ages
35–64 years, ages 65–84 years, and ages $85 years, males, and
females. Due to the small number of events in each subcategory, it
was not possible to stratify by age and gender simultaneously.
Potential Confounders
Adjustments were made for temporal changes in season [23,24],
influenza activity [25], and national smoking prevalence. Season
was designated based upon calendar weeks with winter defined as
December-February, spring as March-May, summer as June-
August, and autumn as September-November. Seasonal adjust-
ment with annual and semi-annual sine and cosine terms yielded
similar effects.
Weekly surveillance data for influenza-like illnesses (ILI) were
available from the Irish Health Protection Surveillance Centre
[26] for the influenza seasons (October-May) of 2000–2001 to
2007–2008. ILI activity for the influenza season of 1999–2000 was
approximated using published data from the European Influenza
Surveillance Scheme [25]. Periods of high ILI activity were
defined as weeks when the reported rate of ILI was $60/100,000,
roughly twice the background rate of ILIs for the Republic of
Ireland.
Monthly smoking prevalence data from a nationally represen-
tative computer-assisted telephone survey of 1,000 persons per
month, ages $15 years, were obtained from the Ireland Office of
Tobacco Control (OTC) [27]. Data were available for the months
of July 2002–December 2007. A linear regression fitted to OTC
data was used to approximate smoking prevalence for 2000–2001.
Annual averages were calculated to adjust for smoking prevalence
in all models.
Presentation of Results
The Poisson model equation estimating weekly morality rates
was expressed as follows:
Log(E(Y ))~b0zb1TimeWzb2BANzb3(TimeW  BAN)z
bk(SP,I ,Season)ze
ð1Þ
where Y denotes the response (weekly mortality), b0 is the model
intercept, b1 is the model coefficient for the weekly time trend
variable, b2 is the coefficient of the indicator variable for smoking
ban policy implementation, b3 is the coefficient of the interaction
between the indicator variable for BAN and the weekly time trend,
bk denotes the effects for a set of covariates of interest (smoking
prevalence-SP, influenza-I, and Season), and e is the model error term.
In the pre-ban period (Figure 1), Ban =0, and the model takes
the form:
Figure 1. Interpretation of model results. The Y axis represents
weekly mortality, the X axis represents Time, and the bold line
represents the monotonic mortality change pre- and post-ban. The
vertical interrupted line represents the time of the smoking ban policy
implementation.
doi:10.1371/journal.pone.0062063.g001
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Log(E(Y ))~b0zb1TimeWzbk(SP,I ,Season)ze ð2Þ
In the post-ban period, Ban =1, thus the model takes the form:
Log(E(Y ))~(b0zb2)z(b1zb3)TimeWz
bk(SP,I ,Season)ze
ð3Þ
where b2 is the change in the log rate ratio for the immediate effect
of the smoking ban and (b1 + b3) is the post-ban rate of change in
mortality, with b3 representing the change in slope after the
ban. For results presentation, rate ratios (RR) were calculated
for the immediate effect coefficients as exp (b2)½ , and weekly
trend effect coefficients were converted to annual change
with exp (b1zb3)  52½ . The 95% confidence intervals (CI)
for the annual trend effect accounted for the overall variance
of the pre- and post-ban slopes with the formula
exp ((b1zb3)  52+1:96  (SQRT(Var(
P
b1,3))  52))
 
, with
Var(
P
b1,3) determined as
P
Var(b1,3)z
P
Cov(b1,3)
 
, whereP
Var(b1,3) is the sum of pre- and post-ban slope variance andP
Cov(b1,3) is the sum of the pre- and post-ban slope covariance
[28,29].
All analyses were conducted using SAS version 9.2, and
statistical modeling was carried out with the SAS GLIMMIX
procedure, allowing adjustment for autocorrelation [30].
Number of Deaths Prevented
The predicted incremental number of deaths that would have
occurred in the absence of a national smoking ban for each of the
3.75 post-ban years (April 2004–December 2007) were calculated
as follows: Predicted deathsi = [Observed deathsj - (Observed
deathsj*Pre-ban annual change)], where i represents each post-ban
year, and j denotes the number of annual deaths from the
preceding year.
Active Smoking Attributable Risk
To determine the extent to which observed mortality reductions
in the first post-ban year were attributable to decreases in active
smoking, the appropriate relative risks for IHD, stroke, and
COPD in active and former smokers were derived from the
published literature [31–36] and applied to an attributable risk
formula previously published by Barone-Adesi et al [31]. To
support these analyses, crude and model-estimated changes in pre-
and post-ban monthly smoking prevalence were calculated to
determine whether ban implementation affected smoking preva-
lence in the population.
Results
During the study period, 215,878 non-trauma deaths occurred
in the Irish population ages $35 years. The population at risk was
1.9 million, mean figures from the 2002 and 2006 censuses.
Seasonal variations in mortality were detected, with the largest
number of deaths occurring in autumn and winter. From 2000–
2007, an overall decrease in mortality rates was observed for all
smoking-related causes of death with decreases becoming more
pronounced in the post-ban period (Figures 2 and S1). In contrast,
non-smoking related mortality showed a sharp increase in 2006
which continued throughout the end of the study period.
From 2000–2007, five periods of increased ILI activity were
identified, with the largest period of increase occurring for eight
consecutive weeks in the latter part of the 2000–2001 influenza
season.
Results of the Poisson regression analyses demonstrated that all-
cause mortality rates decreased in the pre-ban period (RR: 0.98;
95% CI: 0.96–0.99). Similar pre-ban reductions were found for all
cardiovascular causes, IHD, AMI, stroke, and COPD. No pre-ban
mortality effects were seen in the all respiratory category or for
non-smoking related mortality (data not shown).
Overall and gender-specific post-ban results of Poisson regres-
sion analyses are reported in Table 1. Following the implemen-
tation of the ban, an immediate 13% decrease in all-cause
mortality was observed (RR: 0.87; 95% CI: 0.76–0.99). Likewise,
an immediate 26% reduction in mortality was seen in IHD (RR:
0.74; 95% CI: 0.63–0.88), a 32% reduction in stroke (RR: 0.68;
95% CI: 0.54–0.85), and a 38% reduction in COPD (RR: 0.62;
95% CI: 0.46–0.83). IHD and stroke reductions were observed in
both genders, but reductions in all respiratory mortality were seen
only in females (RR: 0.64; 95% CI: 0.42–0.98) driven by
reductions in COPD (RR: 0.47; 95% CI: 0.32–0.70).
In contrast, an immediate 15% decrease was observed for non-
smoking related mortality (RR: 0.85; 95% CI: 0.75–0.97), followed
by a 5% increase each post-ban year (RR: 1.05; 95% CI: 1.02–
1.08). This resulted in a net post-ban increase of 4%. No annual
trend effects in post-ban mortality were detected for any smoking-
related causes of death.
Table 2 displays Poisson regression results stratified by age
category. For ages 35–64 years, an immediate post-ban decrease in
all-cause mortality was observed (RR: 0.79; 95% CI: 0.67–0.93),
followed by annual trend increases in all-cause mortality (RR:
1.06; 95%: 1.02–1.10), resulting in a net post-ban increase of 2%.
For ages 65–84 years, immediate decreases were seen in all-cause
mortality (RR: 0.87; 95% CI: 0.75–0.99). Similar immediate
decreases were observed in IHD, stroke, and COPD for ages 65–
84 years and for ages $85 years.
The inclusion of additional post-ban indicator variables at one,
three, six, and twelve months implied only short-term ban effects.
The testing of false ban implementation dates showed that
immediate mortality effects were either non-significant or smaller
in magnitude compared to actual ban effects. Only AMI showed a
larger effect with the false date of one year pre-ban which
coincided with the announcement by the Irish Minister for Health
that a ban was to come into force on March 29, 2004. Additional
sensitivity analyses demonstrated that model results were largely
unaffected by the 1999–2000 winter peak in mortality, with no
differences in effects observed for any smoking-related causes of
death.
In the absence of a national smoking ban, an estimated 3,726
(95% CI: 2,305–4,629) additional smoking-related deaths would
have occurred. This crude estimate indicates that reductions
occurred in respiratory (up to 2006, 1,896 deaths; 95% CI: 1,517–
2,152), cardiovascular (1,508 deaths; 95% CI: 690–1,926), and
stroke mortality (322; 95% CI: 98–552). No deaths were prevented
in association with non-smoking related mortality.
The resulting mortality decreases following smoking ban
implementation were primarily due to reductions in passive
smoking. The attributable risk calculations for IHD, stroke, and
COPD respectively demonstrated that ,1% of smoking ban
effects was due to decreases in active smoking. Additional analyses
assessing the change in smoking prevalence in the Irish population
as a result of ban implementation showed no observable effects.
Smoking Ban Policy and Mortality Reductions
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Figure 2. Observed Monthly Mortality in the Republic of Ireland, 2000–2007.* *All Respiratory excludes data from year 2007. The vertical
line represents the month of smoking ban implementation. Monthly mortality is displayed rather than weekly for a clearer visual representation of
trends.
doi:10.1371/journal.pone.0062063.g002
Table 1. Multivariate Analysis{ of Overall and Gender-Specific Post-Ban Effects on Mortality Rates`, Ages $35 years, Republic of
Ireland, 2000–2007.
Overall Males Females
Cause of Death
Immediate
Effects
Gradual Effects
per Annum
Immediate
Effects
Gradual Effects
per Annum
Immediate
Effects
Gradual Effects
per Annum
RR (95% CI) RR (95% CI) RR (95% CI) RR (95% CI) RR (95% CI) RR (95% CI)
All-Cause Mortality 0.87 (0.76–0.99) 1.01 (0.98–1.05) 0.87 (0.76–1.00) 1.01 (0.98–1.05) 0.86 (0.74–0.99) 1.01 (0.98–1.05)
All Cardiovascular 0.86 (0.74–1.00) 0.99 (0.95–1.03) 0.85 (0.72–1.02) 0.99 (0.95–1.03) 0.87 (0.72–1.04) 0.99 (0.95–1.04)
Ischemic Heart Disease 0.74 (0.63–0.88) 1.00 (0.96–1.04) 0.71 (0.58–0.86) 1.01 (0.96–1.05) 0.79 (0.64–0.97) 1.00 (0.95–1.05)
Acute Myocardial Infarction 0.89 (0.74–1.08) 0.97 (0.92–1.02) 0.87 (0.70–1.10) 0.97 (0.91–1.02) 0.92 (0.71–1.18) 0.97 (0.91–1.03)
Stroke 0.68 (0.54–0.85) 1.00 (0.95–1.05) 0.66 (0.49–0.89) 0.99 (0.92–1.06) 0.69 (0.53–0.91) 1.01 (0.94–1.07)
All Respiratory* 0.77 (0.54–1.10) 1.01 (0.92–1.10) 0.93 (0.63–1.38) 0.98 (0.89–1.07) 0.64 (0.42–0.98) 1.04 (0.94–1.14)
COPD 0.62 (0.46–0.83) 1.03 (0.96–1.11) 0.78 (0.55–1.12) 1.01 (0.92–1.09) 0.47 (0.32–0.70) 1.07 (0.97–1.16)
Non-Smoking Related Mortality 0.85 (0.75–0.97) 1.05 (1.02–1.08) 0.85 (0.73–1.00) 1.06 (1.02–1.09) 0.84 (0.71–0.99) 1.04 (1.00–1.08)
{Adjusted for time trend, season, influenza, and smoking prevalence.
`Age and gender-standardized according to average census population figures for 2002 and 2006.
*All Respiratory excludes data from year 2007.
doi:10.1371/journal.pone.0062063.t001
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Discussion
The implementation of a national comprehensive smoking ban
in the Republic of Ireland was associated with immediate mortality
reductions in the population aged $35 years. After adjusting for
time trend, seasonal variation, periods of high influenza activity,
and national smoking prevalence, immediate post-ban reductions
were observed in all-cause, IHD, stroke, and COPD mortality,
indicating that the immediate removal of exposure to passive
smoking was effective in preventing early mortality in the
population most at risk.
No gradual post-ban trend effects were seen in any smoking-
related causes of death. These findings are compatible with a
similarly-designed analysis of the effects of the Scottish national
smoking ban on pregnancy complications, which detected
immediate step change reductions, but no gradual effects [37].
Importantly, the most recent meta-analysis of 45 smoking ban
effect studies demonstrated that post-ban risk differences in
cardiovascular deaths and hospital admissions for cardiovascular,
cerebrovascular, and respiratory diseases did not change with a
longer follow-up period [38]. This provides strong epidemiological
evidence that smoking ban effects are seen immediately rather
than gradually.
The decreases in IHD and stroke mortality were evident in both
genders, while decreases in all respiratory and COPD mortality
were noted for females. Stratification by age categories demon-
strated cause-specific reductions for IHD, stroke, and COPD in
ages $65 years. In contrast, for non-smoking related mortality
both immediate post-ban reductions and gradual trend effects
were detected, resulting in an overall post-ban increase.
The post-ban IHD reductions are consistent with the findings of
two Irish studies, one of which demonstrated 12% reductions in
hospital admissions due to acute coronary syndrome (ACS) in the
first year following smoking ban implementation, with further
reductions of 13% in the third post-ban year [6] and the other
which showed an 18% decrease in ACS admissions for the oldest
age groups (50–69 years) in the two post-ban years compared to
the two pre-ban years [7]. Additional corroborative evidence from
other countries includes decreases in out-of-hospital deaths due to
acute coronary events for ages 35–64 years (15%) and ages 65–74
years (16%) one year following implementation of the Italian
national smoking ban [10] and a 6% decrease in out-of-hospital
ACS deaths in the 10 months following implementation of the
Scottish national smoking ban [11].
This study has been the first to demonstrate post-ban reductions
in stroke mortality. These findings are corroborated by prior
studies reporting post-ban reductions in stroke hospital admissions.
One study assessing the effects of a three-phase, province-wide
smoking ban in Ontario, Canada, reported a 24% reduction in
stroke hospital admissions following the second phase of the
legislation, which expanded the existing partial workplace ban to
include restaurants [20]. A study evaluating the effects of the
Arizona statewide smoking ban demonstrated decreases in hospital
admissions due to acute stroke (14%; p=0.001) in the first post-
ban year for counties that did not have prior local smoking
legislation in place [12]. Although a study of the effects of the New
York statewide smoking ban found no effects in stroke admissions
in the first post-ban year, the authors suggested that previously
enforced local smoking restrictions resulted in low secondhand
smoke exposure among residents [18].
This has also been the first study to report smoking ban effects
on respiratory mortality, with decreases in all respiratory mortality
detected in females and decreases in COPD mortality detected
overall, in females, and in persons aged $65 years. These findings
are supported by a study that reported overall decreases in COPD
hospital admissions following a province-wide smoking ban in
Ontario, Canada [20]. Although a recent Irish study did not find
post-ban decreases in COPD hospital admissions in the two post-
ban years compared to the two pre-ban years, a 15% decrease in
overall pulmonary admissions was detected in the same period [7].
The public health importance of the Irish national smoking ban
is strongly demonstrated in estimates of the number of deaths
prevented in the post-ban years. There were 3,726 fewer smoking-
related deaths than would have been expected in the absence of a
smoking ban. This number of prevented deaths is slightly
attenuated when compared to the immediate percent reductions
represented by the model, considering that model estimates
account for gradual trends and other contributing factors.
The results of the attributable risk calculations for IHD
mortality, which demonstrated that ,1% of smoking ban effects
was due to decreases in active smoking, are in concurrence with
the findings of two studies that assessed the cardiovascular health
Table 2. Multivariate Analysis{ of Post-Ban Effects on Mortality Rates by Age Category`, Republic of Ireland, 2000–2007.
Ages 35–64 Years Ages 65–84 Years Ages $85 Years
Cause of Death
Immediate
Effects
Gradual Effects
per Annum
Immediate
Effects
Gradual Effects
per Annum
Immediate
Effects
Gradual Effects
per Annum
RR (95% CI) RR (95% CI) RR (95% CI) RR (95% CI) RR (95% CI) RR (95% CI)
All-Cause Mortality 0.79 (0.67–0.93) 1.06 (1.02–1.10) 0.87 (0.75–0.99) 0.99 (0.96–1.03) 0.94 (0.80–1.10) 1.02 (0.98–1.06)
All Cardiovascular 0.91 (0.69–1.20) 0.98 (0.91–1.05) 0.86 (0.73–1.02) 0.97 (0.93–1.01) 0.86 (0.70–1.05) 1.03 (0.98–1.08)
Ischemic Heart Disease 0.74 (0.53–1.02) 1.01 (0.93–1.08) 0.74 (0.61–0.89) 0.98 (0.94–1.03) 0.78 (0.62–0.99) 1.04 (0.99–1.10)
Acute Myocardial Infarction 0.89 (0.58–1.36) 0.97 (0.86–1.07) 0.90 (0.71–1.13) 0.94 (0.89–1.00) 0.94 (0.71–1.26) 1.01 (0.94–1.09)
Stroke 0.66 (0.37–1.18) 1.00 (0.86–1.14) 0.75 (0.57–0.99) 0.96 (0.90–1.03) 0.61 (0.44–0.83) 1.05 (0.97–1.13)
All Respiratory* 1.59 (0.75–3.39) 0.93 (0.75–1.11) 0.71 (0.47–1.05) 1.01 (0.91–1.10) 0.75 (0.48–1.17) 1.03 (0.92–1.14)
COPD 0.74 (0.32–1.72) 1.04 (0.83–1.24) 0.68 (0.48–0.96) 1.01 (0.92–1.09) 0.49 (0.31–0.78) 1.09 (0.98–1.20)
Non-Smoking Related Mortality 0.72 (0.60–0.86) 1.10 (1.06–1.14) 0.86 (0.75–1.00) 1.03 (0.99–1.06) 1.03 (0.85–1.25) 1.05 (1.01–1.10)
{Adjusted for time trend, season, influenza, and smoking prevalence.
`Age and gender-standardized according to average census population figures for 2002 and 2006.
*All Respiratory excludes data from year 2007.
doi:10.1371/journal.pone.0062063.t002
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effects of the national Italian smoking ban [10,31]. These studies
showed that 0.7% of the estimated post-ban reductions in hospital
admissions due to AMI [31] and ,2% of the estimated post-ban
reductions in hospital admissions and out-of-hospital deaths due to
acute coronary events [10] were due to changes in active smoking
in the first post-ban year.
Attributable risk calculations also showed that reductions in
active smoking accounted for ,1% of post-ban reductions in
stroke and COPD mortality, but no corroborative studies are
available to make comparisons as this is the first study to assess
post-ban effects in these mortality outcomes. Nevertheless, these
results were supported in that no observable change in smoking
prevalence was seen in Ireland as a result of the ban. Together,
these findings suggest that mortality benefits were the result of
reductions in exposure to passive smoking.
Rapid physiological changes occur within minutes to hours of
exposure to passive smoke, increasing risk of adverse cardiovas-
cular and cardiopulmonary events [39,40] and resulting in effects
in non-smokers that are 80% to 90% as large as those experienced
by chronic, active smokers [41]. Exposure to even low levels of
passive smoke decreases oxygen delivery to the heart as the carbon
monoxide from cigarette smoke competes with oxygen for binding
sites on red blood cells [42]. This impaired oxygen delivery to the
heart particularly affects persons with existing cardiovascular
disease, increasing arrhythmias and causing ischemia [42]. This
and other related evidence has resulted in the recommendation
that clinicians advise the families of patients with existing
cardiovascular disease not to smoke while the patient is present
[35,39]. The implementation of the national Irish smoking ban
resulted in an immediate removal of exposure to passive smoke in
workplaces and public places, therefore likely reducing population
risk of experiencing the aforementioned triggers of an adverse
cardiovascular or cardiopulmonary event, particularly for those
with existing disease.
Information from the Survey of Lifestyle, Attitudes, and
Nutrition (SLA´N), a national survey of the Irish population ages
$18 years, was used to investigate trends in cardiovascular and
respiratory risk factors over the study period. For the years 1998
and 2002, SLA´N data were collected through self-administered,
postal questionnaires, but in 2007, data were collected through
face-to-face interviews conducted in the homes of respondents. As
such, 2007 figures may not be directly comparable to those of
previous survey waves. However, obesity prevalence and levels of
physical activity remained steady across the study period. The
percentage of persons consuming over the recommended weekly
alcohol limit decreased in the 2007 survey wave; however, this
result should be interpreted with caution as persons may have
been less likely to report high levels of alcohol consumption in
face-to-face interviews [43].
Due to excise tax increases in Ireland, cigarettes prices increased
by more than 10% in 2000, 2003, and 2007; however, the
estimated effects on smokers aged $35 years were minimal [44].
In 2002, Ireland adopted non-graphic, non-pictorial, health
warnings for cigarette packages, and extended the existing TV
and print media advertising ban to include selected types of
indirect advertising [44]. The advertising ban was further
extended in 2004, but product placements and certain forms of
sponsorship were still allowed [44]. Although these additional
tobacco control interventions may have resulted in synergistic
health improvements with the national smoking ban, their
estimated effects were small and gradual and are thus insufficient
to explain the large mortality reductions detected immediately
following the implementation of the national smoking ban.
A few limitations of this study should be addressed. Direct
adjustments for weather were not possible due to the small number
of weekly mortality events remaining after stratification by age,
gender, and region. Nonetheless, adjustment for seasonal variation
in all models partially accounts for weather effects. Likewise, data
limitations prevented assignment of air pollution measures to
individual mortality events. However, following implementation of
a series of coal bans across Ireland’s major cities from 1990–2000,
large declines in black smoke were noted [45], along with
subsequent reductions in cardiovascular and respiratory mortality
in Dublin [46]. These air quality improvements may partly explain
the pre-ban mortality decreases detected in this study.
A key strength of this study was the use of time-series analysis,
which accounts for secular trends by design and is therefore the
strongest method for assessing the effects of a broad-based
intervention such as a national policy change [47]. Additionally,
this study was unique in that post-ban effects in multiple causes of
death were examined, including deaths due to cerebrovascular and
respiratory diseases which have not been reported in any prior
studies, and the post-ban follow-up period was more extensive
than any other previously reported.
Conclusion
The national smoking ban in the Republic of Ireland was
associated with immediate reductions in early mortality, with
specific benefits observed in cardiovascular, cerebrovascular, and
respiratory causes. Importantly, post-ban risk differences did not
change with a longer follow-up period. As a result of the ban,
unadjusted estimates indicate that 3,726 smoking-related deaths
were likely prevented. This study provides further evidence of the
large public health impacts of smoking ban legislation.
Supporting Information
Figure S1 Weekly Age and Gender-Standardized Mor-
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